Cargando…

164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia

BACKGROUND: High rates of non-prescription dispending of antimicrobials has led to a significant increase in antimicrobial overuse and misuse in Saudi Arabia (SA). The objective of this study was to evaluate antimicrobial utilization following enforcement of a new prescription-only antimicrobial dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Eljaaly, Khalid, Al-Jedai, Ahmed, Almogbel, Yasser, Alqahtani, Nasser, Almudaiheem, Hajer, Awad, Nancy, Alissa, Dema, Assiri, Abdullah, Alaama, Tareef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644302/
http://dx.doi.org/10.1093/ofid/ofab466.366
_version_ 1784610053947392000
author Eljaaly, Khalid
Al-Jedai, Ahmed
Almogbel, Yasser
Alqahtani, Nasser
Almudaiheem, Hajer
Awad, Nancy
Alissa, Dema
Assiri, Abdullah
Alaama, Tareef
author_facet Eljaaly, Khalid
Al-Jedai, Ahmed
Almogbel, Yasser
Alqahtani, Nasser
Almudaiheem, Hajer
Awad, Nancy
Alissa, Dema
Assiri, Abdullah
Alaama, Tareef
author_sort Eljaaly, Khalid
collection PubMed
description BACKGROUND: High rates of non-prescription dispending of antimicrobials has led to a significant increase in antimicrobial overuse and misuse in Saudi Arabia (SA). The objective of this study was to evaluate antimicrobial utilization following enforcement of a new prescription-only antimicrobial dispensing policy in the community pharmacy setting in SA. METHODS: Data were extracted from the IQVIA database between May 2017 and May 2019. Antimicrobial consumption rate based on the sales, defined daily dose in grams (DDD), DDD/1000 inhabitants’/day (DID), and antimicrobial claims for pre-policy (May 2017 to April 2018) and post-policy (June 2018 to May 2019) periods was assessed. RESULTS: Overall antimicrobial utilization slightly declined (~9-10%) in post-policy vs. pre-policy period (sales, 31,334 vs.34,492 thousand units; DDD, 183,134 vs. 202,936 thousand grams), with an increase in the number of claims (~16%) after policy implementation. There was a sudden drop in the consumption rate immediately after policy enforcement; however, the values increased subsequently, matching closely to the pre-policy values. Consumption patterns were similar in both periods. Penicillins were the most commonly used antimicrobial (sales, 14,700 - 11,648 thousand units; DDD, 71,038 - 91,227 thousand grams; DID, 2.88 - 3.78). For both the periods, the highest dip in utilization was observed in July (sales, 1,027 - 1,559 thousand units; DDD, 6,194 - 9,399 thousand grams), while the highest spike was in March/October (sales, 3,346 - 3,884 thousand units; DDD, 22,329 - 19,453 thousand grams). CONCLUSION: Non-prescription antimicrobial utilization reduced minimally following policy implementation in the community pharmacy setting across SA. Measures to aid effective implementation of prescription-only regulations are necessary. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644302
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86443022021-12-06 164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia Eljaaly, Khalid Al-Jedai, Ahmed Almogbel, Yasser Alqahtani, Nasser Almudaiheem, Hajer Awad, Nancy Alissa, Dema Assiri, Abdullah Alaama, Tareef Open Forum Infect Dis Poster Abstracts BACKGROUND: High rates of non-prescription dispending of antimicrobials has led to a significant increase in antimicrobial overuse and misuse in Saudi Arabia (SA). The objective of this study was to evaluate antimicrobial utilization following enforcement of a new prescription-only antimicrobial dispensing policy in the community pharmacy setting in SA. METHODS: Data were extracted from the IQVIA database between May 2017 and May 2019. Antimicrobial consumption rate based on the sales, defined daily dose in grams (DDD), DDD/1000 inhabitants’/day (DID), and antimicrobial claims for pre-policy (May 2017 to April 2018) and post-policy (June 2018 to May 2019) periods was assessed. RESULTS: Overall antimicrobial utilization slightly declined (~9-10%) in post-policy vs. pre-policy period (sales, 31,334 vs.34,492 thousand units; DDD, 183,134 vs. 202,936 thousand grams), with an increase in the number of claims (~16%) after policy implementation. There was a sudden drop in the consumption rate immediately after policy enforcement; however, the values increased subsequently, matching closely to the pre-policy values. Consumption patterns were similar in both periods. Penicillins were the most commonly used antimicrobial (sales, 14,700 - 11,648 thousand units; DDD, 71,038 - 91,227 thousand grams; DID, 2.88 - 3.78). For both the periods, the highest dip in utilization was observed in July (sales, 1,027 - 1,559 thousand units; DDD, 6,194 - 9,399 thousand grams), while the highest spike was in March/October (sales, 3,346 - 3,884 thousand units; DDD, 22,329 - 19,453 thousand grams). CONCLUSION: Non-prescription antimicrobial utilization reduced minimally following policy implementation in the community pharmacy setting across SA. Measures to aid effective implementation of prescription-only regulations are necessary. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644302/ http://dx.doi.org/10.1093/ofid/ofab466.366 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Eljaaly, Khalid
Al-Jedai, Ahmed
Almogbel, Yasser
Alqahtani, Nasser
Almudaiheem, Hajer
Awad, Nancy
Alissa, Dema
Assiri, Abdullah
Alaama, Tareef
164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
title 164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
title_full 164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
title_fullStr 164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
title_full_unstemmed 164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
title_short 164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
title_sort 164. restriction of antimicrobials dispensing without prescription on a national level: impact on the overall antimicrobial utilization in community pharmacies in saudi arabia
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644302/
http://dx.doi.org/10.1093/ofid/ofab466.366
work_keys_str_mv AT eljaalykhalid 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT aljedaiahmed 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT almogbelyasser 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT alqahtaninasser 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT almudaiheemhajer 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT awadnancy 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT alissadema 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT assiriabdullah 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia
AT alaamatareef 164restrictionofantimicrobialsdispensingwithoutprescriptiononanationallevelimpactontheoverallantimicrobialutilizationincommunitypharmaciesinsaudiarabia